Braidwell’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,379,577
| Closed | -$17.2M | – | 78 |
|
|
2024
Q1 | $17.2M | Sell |
3,379,577
-2,338,900
| -41% | -$11.9M | 0.55% | 54 |
|
|
2023
Q4 | $34.3M | Buy |
5,718,477
+355,497
| +7% | +$2.13M | 1.26% | 31 |
|
|
2023
Q3 | $38M | Buy |
5,362,980
+2,571,100
| +92% | +$18.2M | 1.2% | 34 |
|
|
2023
Q2 | $19.7M | Buy |
2,791,880
+846,746
| +44% | +$5.96M | 0.64% | 54 |
|
|
2023
Q1 | $16.2M | Buy |
+1,945,134
| New | +$16.2M | 0.54% | 58 |
|